Modeling skin permeability in risk assessment

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 287-298

  Fitzpatrick, Dara ^a   Golden, Darach ^b   Corish, John ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885948713     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Worth AP, Bassan A, Gallegos A, et al. The Characterisation of (Quantitative) Structure-Activity Relationships: Preliminary Guidance (EUR 21866 EN), 2006. (Accessed October 2007 at http://ecb.jrc.it/DOCUMENTS/QSAR/)
2. Watson GW, Wells RPK, Willock DJ, Hutchings GJ. A comparison of the adsorption and diffusion of hydrogen on the (111) surfaces of Ni, Pd, and Pt from density functions, l theory calculations. J Phys Chem B 2001; 105:4889-94.
3. Rurali R, Heranadez E, Godignon P, Rebollo J, Ordejon P. First principles studies of vacancy diffusion in SiC. Comput Mater Sci 2003; 27:36-42.
4. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992; 9:663-9.
5. Flynn GL. Physicochemical determinants of skin absorption. In:Gerrity TR, Henry CJ, eds. Principles of Route to Route Extrapolation for Risk Assessment. New York: Elsevier, 1990;93-127.
6. Pugh WJ, Hadgraft J. Ab initio prediction of human skin permeability coefficients. Int J Pharm 1994; 103:163-78.
7. Cronin MT, Dearden JC, Moss GP, Murray-Dickson P. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur J Pharm Sci 1999; 7:325-30.
8. Patel H, ten Berge W, Cronin MTD. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 2002; 48:603-13.
9. Katritzky A, Dobchev DA, Fara DC, et al. Skin permeation rate as a function of chemical structure. J Med Chem 2006; 49:3305-14.
10. Neumann D, Kohlbacher O, Merkwirth C, Lengauer T. A fully computational model for predicting percutaneous drug absorption. J Chem Inf Model 2006; 46:424-9.
11. Roberts MS, Pugh WJ, Hadgraft J, Watkinson AC. Epidermal permeability-penetrant structure relationships: 1. An analysis of methods of predicting penetration of monofunctional solutes from aqueous solutions. Int J Pharm 1995; 126:219-33.
12. Vecchia B, Bunge A. Partitioning of chemicals into skin: results and predictions. In:Guy RH, Hadgraft J, eds. Transdermal Drug Delivery. New York: Marcel Dekker, 2002;143-98.
13. Abraham MH, Martins F. Human skin permeation and partition: general linear freeenergy relationship analyses. J Pharm Sci 2004; 93:1508-23.
14. Degim T, Hadgraft J, Albasmi S, Özkan Y. Prediction of skin penetration using artificial neural network (ANN) modeling. J Pharm Sci 2003; 92:656-64.
15. Pugh WJ, Degim IT, Hadgraft J. Epidermal permeability-penetrant structure relationships:4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. Int J Pharm 2000; 197:203-11.
16. Magnusson BM, Pugh WJ, Roberts MS. Simple rules defining the potential of compounds for transdermal delivery or toxicity. Pharm Res 2004; 21:1047-54.
17. Pannier AK, Brand RM, Jones DD. Fuzzy modeling of skin permeability coefficients. Pharm Res 2003; 20:143-8.
18. Magnusson BM, Anissimov YG, Cross SE, Roberts MS. Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 2004; 122:993-9.
19. Fitzpatrick D, Corish J, Hayes B. Modelling skin permeability in risk assessment-the future. Chemosphere 2004; 55:1309-14.
20. Wittiker C, Walker JD, Gay DA, Neal MW. OSHA chemicals referred to the ISCA Interagency Testing Committee for percutaneous absorption testing and prioritization and analysis of OSHA skin notation criteria. Toxicologist 1993; 13:101.
21. Frasch HF, Landsittel DP. Regarding the sources of data analyzed with quantitative structure-skin permeability relationship methods (commentary on “Investigation of the mechanism of flux across the human skin in vitro by quantitative structure-permeability relationships”). Eur J Pharm Sci 2002; 15:399-403.
22. Degim TI, Pugh WJ, Hadgraft J. Skin permeability data: anomalous results. Int J Pharm 1998; 170:129-33.
23. Hadgraft J, du Plessis J, Goosen C. The selection of non-steroidal anti-inflammatory agents for dermal delivery. Int J Pharm 2000; 207:31-7.
24. Gregoire S, Guy RH. Prediction of chemical absorption across the skin under cosmetic/dermatological conditions of use. In: 10th International Conference on Perspectives in Percutaneous Penetration. La Grande Motte, France, 2006.
25. Vecchia B, Bunge A. Skin absorption databases and predictive equations. In:Guy RH, Hadgraft J, eds. Transdermal Drug Delivery. New York: Marcel Dekker, 2002;57-141.
26. Padmanabhan RV, Surnam JM. PCT, WO91/16077, A61K, 74/21, 1991.
27. Sangster J. Octanol-Water Partition Coefficients. Fundamentals and Physical Chemistry. Chichester: Wiley, 1997.
28. Finizio A, Vighi M, Sandroni D. Determination of n-octanol/water partition coefficient of pesticides. Critical review and comparison of methods. Chemosphere 1997; 34:131-61.
29. Valko K. Application of HPLC based measurements of lipophilicity to model biological distribution. J Chromatogr A 2004; 1037:299-310.
30. Gramatica P, Pilutti P. Evaluation of different statistical approaches for the validation of quantitative structure activity relationships, 2006. (Accessed October 2007 at http://ecb. jrc.it/DOCUMENTS/QSAR/)
31. Jaworska J, Nikolova-Jeliazkova N, Aldenberg T. Review of the methods assessing the applicability domains of SARs and QSARs, 2006. (Accessed October 2007 at http://ecb. jrc.it/DOCUMENTS/QSAR/AD_methods.zip)
32. Jaworska JS, Comber M, Auer C, Van Leeuwen CJ. Summary of a workshop on regulatory acceptance of (Q)SARs for human health and environmental endpoints. Environ Health Perspect 2003; 111:1358-60.
33. Milmo S. Ready for REACH? Chemistry World 2007; 4(4):56.
34. Bunge AL, Cleek RL. A new method for estimating dermal absorption from chemical exposure: 2. Effect of molecular weight and octanol-partitioning. Pharm Res 1995; 12:88-95.
35. Kruse J, Golden D, Wilkinson S, Williams F, Kezic S, Corish J. Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. J Pharm Sci 2007; 96:682-703.
36. Annisimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. J Pharm Sci 1999; 88:1201-9.
37. Annisimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 2001; 90:504-20.
38. Wilschut A, ten Berge WF, Robinson P J, Mckone TE. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995; 30:1275-96.